Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation

Nasal potential difference (NPD) is used as a biomarker of the cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC) activity. We evaluated methods to detect changes in chloride and sodium transport by NPD based on a secondary analysis of a Phase II CFTR-mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Steven M., Liu, Bo, Hill, Aubrey, Hathorne, Heather, Cohen, Morty, Beamer, John R., Accurso, Frank J., Dong, Qunming, Ordoñez, Claudia L., Stone, Anne J., Olson, Eric R., Clancy, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724869/
https://www.ncbi.nlm.nih.gov/pubmed/23922647
http://dx.doi.org/10.1371/journal.pone.0066955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724869/
https://www.ncbi.nlm.nih.gov/pubmed/23922647
http://dx.doi.org/10.1371/journal.pone.0066955

Ejemplares similares